IDiyas

For the Inventor, By the Inventor

Montreal, Canada

Anouk Leblanc

USPTO Granted Patents = 8

Average Co-Inventor Count = 5.6

ph-index = 8

Forward Citations = 610(Granted Patents)


Company Filing History:

goldMedal8 out of 28 
 
Conjuchem, Inc.
 patents

Years Active: 2001-2012

Loading Chart...
8 patents (USPTO):Explore Patents
1. 8093206 - Methods involving long lasting synthetic exendin-4 peptide conjugates (2012-01-10),
2. 8084414 - Methods involving long lasting synthetic exendin-4-peptide conjugates (2011-12-27),
3. 8080516 - Long lasting synthetic exendin-4 peptide conjugates (2011-12-20),
4. 6887849 - Long lasting synthetic glucagon-like peptide {GLP-1} (2005-05-03),
5. 6821949 - Long lasting synthetic glucagon-like peptide (GLP-1) (2004-11-23),
6. 6593295 - Long lasting insulinotropic peptides (2003-07-15),
7. 6514500 - Long lasting synthetic glucagon like peptide {GLP-!} (2003-02-04),
8. 6329336 - Long lasting insulinotropic peptides (2001-12-11),

Title: Anouk Leblanc: Innovator in Diabetes Treatment

Introduction

Anouk Leblanc is a prominent inventor based in Montreal, Canada, known for her significant contributions to the field of diabetes treatment. With a total of eight patents to her name, she has made remarkable advancements in the development of modified insulinotropic peptides.

Latest Patents

Among her latest patents, Anouk has developed methods involving long-lasting synthetic exendin-4 peptide conjugates. These modified insulinotropic peptides are capable of forming a peptidase-stabilized insulinotropic peptide. Furthermore, these peptides can form covalent bonds with one or more blood components to create a conjugate. The conjugates may be formed either in vivo or ex vivo. The modified peptides are specifically designed to be administered to treat humans suffering from diabetes and other related diseases.

Career Highlights

Anouk Leblanc has established herself as a key figure in her field through her innovative research and development efforts. Her work has not only advanced scientific understanding but has also paved the way for new therapeutic options for patients with diabetes.

Collaborations

Anouk collaborates with notable colleagues such as Benoit L'Archeveque and Darren L. Holmes, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Anouk Leblanc's contributions to diabetes treatment through her patented inventions highlight her role as a leading inventor in the medical field. Her work continues to impact the lives of many individuals living with diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…